Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
about
An atypical E3 ligase zinc finger protein 91 stabilizes and activates NF-kappaB-inducing kinase via Lys63-linked ubiquitinationAutophagy and NF-kappaB: fight for fatep100 Deficiency is insufficient for full activation of the alternative NF-κB pathway: TNF cooperates with p52-RelB in target gene transcriptionSelf-termination of the terminatorMutations in NFKB2 and potential genetic heterogeneity in patients with DAVID syndrome, having variable endocrine and immune deficienciesRelB-dependent stromal cells promote T-cell leukemogenesisGlycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapyCrosstalk in inflammation: the interplay of glucocorticoid receptor-based mechanisms and kinases and phosphatasesEpigenetic repression of PDZ-LIM domain-containing protein 2: implications for the biology and treatment of breast cancer.The glutaredoxin/S-glutathionylation axis regulates interleukin-17A-induced proinflammatory responses in lung epithelial cells in association with S-glutathionylation of nuclear factor κB family proteins.An RNA interference screen identifies the Deubiquitinase STAMBPL1 as a critical regulator of human T-cell leukemia virus type 1 tax nuclear export and NF-κB activation.Tribbles 2 (Trib2) is a novel regulator of toll-like receptor 5 signalingPathogenetic mechanisms in gastric cancer.Classical NF-kappaB activation negatively regulates noncanonical NF-kappaB-dependent CXCL12 expression.DNA methylation-dependent repression of PDZ-LIM domain-containing protein 2 in colon cancer and its role as a potential therapeutic targetNF-κB signaling is required for XBP1 (unspliced and spliced)-mediated effects on antiestrogen responsiveness and cell fate decisions in breast cancer18β-glycyrrhetinic acid inhibits periodontitis via glucocorticoid-independent nuclear factor-κB inactivation in interleukin-10-deficient mice.CARMA3: A novel scaffold protein in regulation of NF-κB activation and diseasesGenomics of the NF-κB signaling pathway: hypothesized role in ovarian cancer.Human T-cell lymphotropic virus: a model of NF-κB-associated tumorigenesisIdentification of biomarkers that distinguish chemical contaminants based on gene expression profiles.Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway.Oncovirus Kaposi sarcoma herpesvirus (KSHV) represses tumor suppressor PDLIM2 to persistently activate nuclear factor κB (NF-κB) and STAT3 transcription factors for tumorigenesis and tumor maintenance.NF-κB and cancer: a paradigm of Yin-Yang.The complex interplay between autophagy and NF-κB signaling pathways in cancer cellsExtracellular Hsp90 serves as a co-factor for NF-κB activation and cellular pathogenesis induced by an oncogenic herpesvirus.Endoproteolytic processing of C-terminally truncated NF-kappaB2 precursors at kappaB-containing promotersBAG-1 interacts with the p50-p50 homodimeric NF-κB complex: implications for colorectal carcinogenesisThe tumor suppressor gene WWOX links the canonical and noncanonical NF-κB pathways in HTLV-I Tax-mediated tumorigenesisSystems genetics of the nuclear factor-κB signal transduction network. I. Detection of several quantitative trait loci potentially relevant to aging.NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function.RAC1b overexpression stimulates proliferation and NF-kB-mediated anti-apoptotic signaling in thyroid cancer cells.Cooperation between classical and alternative NF-κB pathways regulates proinflammatory responses in epithelial cells.Role of WWOX and NF-κB in lung cancer progressionPDLIM2 restricts Th1 and Th17 differentiation and prevents autoimmune disease.NF-kappa B as a therapeutic target in autoimmune disease.Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy.The IkappaB kinases IKKalpha and IKKbeta are necessary and sufficient for skeletal muscle atrophy.PDLIM2 suppresses human T-cell leukemia virus type I Tax-mediated tumorigenesis by targeting Tax into the nuclear matrix for proteasomal degradationA new cross-talk between the aryl hydrocarbon receptor and RelB, a member of the NF-kappaB family
P2860
Q24294345-D557DBCE-09FA-4628-80DF-32FB7C7C5BA9Q24658157-94D52827-48E5-4D43-8461-4690A8E711BBQ27324491-0E57C5CD-11BD-4B48-8D55-7201D92BA8F6Q28118772-DA43FB01-B7D7-4A35-8458-445EC5CE07CEQ28254194-E7D619C2-FF3C-4047-9CF7-705956F32E24Q33348553-31447C28-CF78-48F8-9134-80EDF647927BQ33437264-106D7D9B-0273-47E4-9042-067964898367Q33636430-BCAAAED1-ED2F-4C89-A58F-552DDDAE48B7Q33782392-5742ED6C-9AB3-4318-9F9E-CB4EDEEB1542Q33954291-F4B0469B-2502-40C3-8FC2-105947577635Q34132731-39D035B6-54AA-40EE-A323-8B9C7251DB3BQ34136951-DABC7BC8-104E-44EB-9D05-F9DEF0266A2BQ34326627-7D5435F6-A527-4B35-AAA1-82E118480912Q34352064-C8363EE1-AC9F-4104-AEC6-202CEB1984CEQ34412280-5743D641-9386-47E1-90CB-2A0377FE0395Q34745409-DB37A7F4-AC3B-42CF-AD10-FD5A94B08F75Q34786841-C75C38B8-964F-4482-A324-2E22AD54265BQ34878582-499A3E34-CDC5-4C11-B3B5-F2178DC4C1BFQ35058278-1A28EEF0-3312-4FCC-8C86-96CE9B83325FQ35090534-CC7670A2-B7D1-44B6-AD84-9A5D41B21343Q35134347-981F2E8B-B248-4E85-A19A-B47C820FA961Q35160414-D6B8871C-6B91-406B-A84F-B5F5EB8B4648Q35199327-8386A903-01DF-4FF7-BEFC-6A34F2275429Q35232248-B0C679AC-6515-4C21-A53F-F979EAF1809CQ35298106-7DF8734F-7B49-46A7-9A82-72A44B690F9AQ35298119-7F7136A6-36C5-4FA7-AE2D-D1DC26DA974FQ35720569-BD3C8FF0-EA25-493D-AFDD-DC12C9E786C7Q35737918-97312C21-75E5-45E4-99FE-5C2F557AAE65Q35868351-A7D24825-4DA5-43EC-A7CB-95B9F5778C75Q35875216-E5D97D70-DF27-4C15-8DBD-C1AEDA2BD929Q35994472-B3F2F74B-8B0F-42E2-920E-46EE96EA4F91Q36289839-69B22EED-8753-499E-AFFE-7F09D218BA3FQ36369929-2063E9A1-CC55-4B87-A8D9-21C50279ABBDQ36468642-4AEE6F05-F255-42D9-89EF-21E3DF8D380CQ36527226-992F2973-B4B4-4ABF-81D9-B856C37B1814Q36709522-4BEE270E-3EC5-424C-A4D5-2C4A524BF543Q37010500-3ECCF5DE-8E28-41AE-89F2-4C0575545959Q37072407-0CFF4A0E-9BD3-4E47-9ADB-75F8AD4D3A4EQ37176572-FBA8970F-91C6-4AF7-A4FD-F71DF9AB526AQ37207403-15671441-45C3-420F-BB23-14A58D9D51AA
P2860
Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
@ast
Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
@en
type
label
Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
@ast
Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
@en
prefLabel
Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
@ast
Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
@en
P2093
P1476
Alternative pathways of NF-kappaB activation: a double-edged sword in health and disease.
@en
P2093
Arnold B Rabson
Guoliang Qing
Gutian Xiao
Wise Young
Zhaoxia Qu
P304
P356
10.1016/J.CYTOGFR.2006.04.005
P577
2006-06-21T00:00:00Z